RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Murali Yallapu to Antineoplastic Agents

This is a "connection" page, showing publications Murali Yallapu has written about Antineoplastic Agents.
Connection Strength

3.411
  1. Tiwari R, Delossantos J, Ghali ENHK, Chavez LA, Chaudhari VS, Han S, Chauhan SC, Yallapu MM. Biodegradable PCL-PLGA Electrospun Nanofibers for Localized Cancer Therapy. ACS Appl Bio Mater. 2026 May 18; 9(10):4579-4593.
    View in: PubMed
    Score: 0.533
  2. Karumuru V, Dhasmana A, Mamidi N, Chauhan SC, Yallapu MM. Unveiling the potential of Urolithin A in Cancer Therapy: Mechanistic Insights to Future Perspectives of Nanomedicine. Nanotheranostics. 2025; 9(2):121-143.
    View in: PubMed
    Score: 0.496
  3. Nagesh PKB, Chowdhury P, Hatami E, Kumari S, Kashyap VK, Tripathi MK, Wagh S, Meibohm B, Chauhan SC, Jaggi M, Yallapu MM. Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence. ACS Appl Mater Interfaces. 2019 Oct 23; 11(42):38537-38554.
    View in: PubMed
    Score: 0.338
  4. Chowdhury P, Roberts AM, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM. Magnetic nanoformulations for prostate cancer. Drug Discov Today. 2017 08; 22(8):1233-1241.
    View in: PubMed
    Score: 0.286
  5. Yallapu MM, Khan S, Maher DM, Ebeling MC, Sundram V, Chauhan N, Ganju A, Balakrishna S, Gupta BK, Zafar N, Jaggi M, Chauhan SC. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer. Biomaterials. 2014 Oct; 35(30):8635-48.
    View in: PubMed
    Score: 0.235
  6. Yallapu MM, Ebeling MC, Khan S, Sundram V, Chauhan N, Gupta BK, Puumala SE, Jaggi M, Chauhan SC. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Mol Cancer Ther. 2013 Aug; 12(8):1471-80.
    View in: PubMed
    Score: 0.217
  7. Yallapu MM, Jaggi M, Chauhan SC. Design and engineering of nanogels for cancer treatment. Drug Discov Today. 2011 May; 16(9-10):457-63.
    View in: PubMed
    Score: 0.187
  8. Yallapu MM, Jaggi M, Chauhan SC. Poly(?-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells. Macromol Biosci. 2010 Oct 08; 10(10):1141-51.
    View in: PubMed
    Score: 0.181
  9. Yallapu MM, Gupta BK, Jaggi M, Chauhan SC. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci. 2010 Nov 01; 351(1):19-29.
    View in: PubMed
    Score: 0.176
  10. Yallapu MM, Jaggi M, Chauhan SC. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces. 2010 Aug 01; 79(1):113-25.
    View in: PubMed
    Score: 0.175
  11. Choppadandi M, Parmar K, Ghosh S, K SR, Rao KH, Singh AA, Sharma P, Kumar H, Turubilli HL, Chauhan SC, Yallapu MM, Kapusetti G. Self-Regulated Cobalt-Zinc-Ferrite Nanoprobe for Targeted Chemomagnetic Hyperthermia in Cancer Therapy. ACS Appl Mater Interfaces. 2025 Dec 31; 17(52):70454-70467.
    View in: PubMed
    Score: 0.129
  12. Chauhan N, Maher DM, Yallapu MM, B Hafeez B, Singh MM, Chauhan SC, Jaggi M. A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth. Sci Rep. 2019 07 29; 9(1):10917.
    View in: PubMed
    Score: 0.083
  13. Kumar BNP, Puvvada N, Rajput S, Sarkar S, Mahto MK, Yallapu MM, Pathak A, Emdad L, Das SK, Reis RL, Kundu SC, Fisher PB, Mandal M. Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer. Mol Pharm. 2018 07 02; 15(7):2698-2713.
    View in: PubMed
    Score: 0.077
  14. Nagesh PKB, Johnson NR, Boya VKN, Chowdhury P, Othman SF, Khalilzad-Sharghi V, Hafeez BB, Ganju A, Khan S, Behrman SW, Zafar N, Chauhan SC, Jaggi M, Yallapu MM. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer. Colloids Surf B Biointerfaces. 2016 Aug 01; 144:8-20.
    View in: PubMed
    Score: 0.066
  15. Zaman MS, Chauhan N, Yallapu MM, Gara RK, Maher DM, Kumari S, Sikander M, Khan S, Zafar N, Jaggi M, Chauhan SC. Curcumin Nanoformulation for Cervical Cancer Treatment. Sci Rep. 2016 Feb 03; 6:20051.
    View in: PubMed
    Score: 0.065
  16. Ganju A, Yallapu MM, Khan S, Behrman SW, Chauhan SC, Jaggi M. Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resist Updat. 2014 Apr; 17(1-2):13-23.
    View in: PubMed
    Score: 0.058
  17. Yallapu MM, Othman SF, Curtis ET, Bauer NA, Chauhan N, Kumar D, Jaggi M, Chauhan SC. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomedicine. 2012; 7:1761-79.
    View in: PubMed
    Score: 0.050
  18. Kashyap VK, Sharma BP, Pandey D, Singh AK, Peasah-Darkwah G, Singh B, Roy KK, Yallapu MM, Chauhan SC. Small Molecule with Big Impact: Metarrestin Targets the Perinucleolar Compartment in Cancer Metastasis. Cells. 2024 12 12; 13(24).
    View in: PubMed
    Score: 0.030
  19. Malik S, Sikander M, Bell N, Zubieta D, Bell MC, Yallapu MM, Chauhan SC. Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy. J Ovarian Res. 2024 Aug 08; 17(1):161.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support